Condensed Imidazolo Derivative Synthesis via Salt-Mediated Cyclization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing 4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazole-5-yl)-3-fluorobenzonitrile are not ideal for industrial scale-up due to the need for additional synthetic steps and the formation of side products, which complicates the production of high yields and purity.

Innovation Solution

A process involving the reaction of a compound with a base in the presence of an alkaline- or alkaline earth metal salt to suppress the elimination of a leaving group and reduce the formation of side products, allowing for high-yield and high-purity production of 4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazole-5-yl)-3-fluorobenzonitrile in a single step.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the known process with auxiliary ester moiety is used, then cyclization can be achieved, but the number of synthetic steps increases

Engineering Contradiction:
Improvecyclization successVSAvoidnumber of synthetic steps
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention removes the auxiliary ester moiety from the synthetic pathway entirely. Instead of installing the ester group to activate the benzylic position and then removing it later, the process directly cyclizes the compound of formula VI using a base, eliminating the need for the auxiliary activating group and its subsequent removal steps.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention performs the cyclization reaction directly on the compound of formula VI without preliminary activation. The base is applied directly to the chloroethyl compound to induce intramolecular cyclization, bypassing the need for prior esterification to activate the benzylic position.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If direct cyclization of compound VI with base is attempted, then the number of steps is reduced, but elimination of HCl occurs instead of cyclization

Engineering Contradiction:
Improvenumber of synthetic stepsVSAvoidcyclization success
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention changes the reaction parameters by selecting specific bases (such as alkali metal hydroxides, carbonates, or bicarbonates) and controlling the reaction conditions (temperature, solvent, stoichiometry) to favor cyclization over elimination. These parameter adjustments enable the direct cyclization of compound VI to proceed successfully without HCl elimination.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If auxiliary ester moiety is introduced, then cyclization can proceed, but additional steps for introduction and removal are required

Engineering Contradiction:
Improvecyclization capabilityVSAvoidsynthetic steps for ester introduction and removal
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The invention extracts the auxiliary ester moiety from the synthetic pathway. The process achieves successful cyclization without introducing the ester activating group, thereby eliminating both the introduction step and the subsequent removal step that would otherwise be required.

Inventive Principle:
Principle #2Taking out (Extraction)

4Quantity of substance

If the known process is used, then the compound can be produced, but side products are formed reducing purity

Engineering Contradiction:
Improvecompound productionVSAvoidpurity of product
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The invention optimizes reaction parameters including base selection, temperature control, and reaction time to minimize side product formation. By carefully controlling these parameters during the direct cyclization of compound VI, the process achieves high product purity while maintaining efficient production.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in reproducible high yields and high purity of the compound, with reduced levels of side products, making it suitable for industrial scale-up and pharmaceutical applications.

Implementation Method 1

the presence of an alkaline- or alkaline earth metal salt suppressed elimination of the leaving group from the compound of formula VII when reacting the compound of formula VII with a base

Methodology Applied
Scientific EffectChemical reaction suppression:

Implementation Method 2

The inventors have further found that the use of an alkaline- or alkaline earth metal salt suppressed the formation of 3-(2-(1H-imidazol-5-yl)ethyl)-2-(4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorophenyl)-1H-indole-6-carbonitrile (formula (VIII))

Methodology Applied
Scientific EffectSide reaction suppression:

Implementation Method 3

reacting a compound of formula VII with a base in the presence of an alkaline- or alkaline earth metal salt (MX in scheme 1) to form the compound of formula I

Methodology Applied
Scientific EffectCyclization reaction: Chemical Bonding

Data Source

PatentEP3250555B1Process for the production of condensed imidazolo derivatives
Publication Date: 2021.03.03 RECORDATI AG
  • EP3250555B1 patent drawing
  • EP3250555B1 patent drawing
  • EP3250555B1 patent drawing

AI summary

The present invention relates to a process for providing the compound of formula I, comprising the step of reacting a compound of formula VII with a base in the presence of an alkaline- or alkaline earth metal salt (MX), wherein LG is a leaving group. The presence of an alkaline- or alkaline earth metal salt was surprisingly found to render said reaction highly reliable in terms of the yield and purity of the compound of formula I obtained. In a further aspect, the present invention relates to the compound of formula I, having less than an amount of 1.50% or less than an amount of 1.25% or less than an amount of 1.00% or less than an amount of 0.75% or less than an amount of 0.50% or less than an amount of 0.25% or less than an amount of 0.10% of the compound of formula VIII.